Objective: The aim of this study to determine the prevalence of anxiety disorders in publically treated psychiatric inpatients with a DSM-IV diagnosis of schizophrenia, schizoaffective disorder or bipolar disorder.
Method: Using the Structured Clinical Interview for DSM-III-R (SCID), 100 consecutive inpatients with a psychotic disorder were examined for the presence or absence of an anxiety disorder. Questionnaire measures of phobias, obsessive-compulsive and general anxiety symptoms were also applied.
Results: The prevalences of social phobia (17%), obsessiv-ompulsive disorder (13%) and generalised anxiety disorder in schizophrenia were relatively high, as were prevalences of obsessive-compulsive (30%) and panic disorder (15%) in bipolar disorder. The proportion of subjects with an anxiety disorder (4345%) was almost identical across the three psychoses, with some evidence of gender differences. Although self-ratings of overall psychiatric symptoms were significantly elevated in those with anxiety disorders, hospital admission rates were not.
Conclusions: Almost none of those with anxíeGty disorders were being treated for them, primarily because the severity of the acute psychotic illness required full diagnostic and therapeutic attention. Patients were generally discharged as soon as their psychotic episode was resolved, with little recognition of the presence of an anxiety disorder. Given that anxiety disorders are relatively responsive to treatment, greater awareness of their comorbidity with psychosis should yield worthwhile clinical benefits.
WittchenH.Cormorbidity of mood disorders. British Journal of Psychiatry1996; 168(Suppl. 30):7–134.
2.
ArgyleN.Panic attacks in chronic schizophrenia. British Journal of Psychiatry1990; 157:430–433.
3.
CutlerJLSirisSG‘Panic-like’ symptomatology in schizophrenic and schizoaffective patients with postpsychotic depression. Comprehensive Psychiatry1991; 32:465–473.
4.
PennDLHopeDASpauldingWKuceraJ.Social anxiety in schizophrenia. Schizophrenia Research1994; 11:277–284.
5.
FentonWSMcGlashenTHThe prognostic significance of obsessive–compulsive symptoms in schizophrenia. American Journal of Psychiatry1986; 143:437–441.
6.
BermanIKalinowskiABermanSMLenguaJGreenAIObsessive and compulsive symptoms in chronic schizophrenia. Comprehensive Psychiatry1995; 36:6–10.
7.
KrugerSCookeRGHaseyGMJornaTPersadE.Cormorbidity of obsessive compulsive disorder in bipolar disorder. Journal of Affective Disorders1995; 34:117–120.
8.
StrakowskiSMTohenMStollALFaeddaGLGoodwinDCComorbidity in mania at first hospitalization. American Journal of Psychiatry1992; 149:554–556.
9.
ChenYDilsaverSCComorbidity for obsessive–compulsive disorder in bipolar and unipolar disorders. Psychiatry Research1995; 59:57–64.
10.
ChenYDilsaverSCComorbidity of panic disorder in bipolar illness: evidence from the Epidemiologic Catchment Area survey. American Journal of Psychiatry1995; 152:280–282.
11.
YoungTCookeRGRobbJLevittAJJoffeR.Anxious and non-anxious bipolar disorder. Journal of Affective Disorders1993; 29:49–52.
12.
SpitzerRLWilliamsJBGibbonMFirstMBThe structured clinical interview for DSM-III-R (SCID). 1: History, rationale and description. Archives of General Psychiatry1992; 49:624–629.
13.
HallamRSHafnerRJFears of phobic patients: factor analyses of self-report data. Behaviour Research and Therapy1978; 16:1–6.
14.
MarksIMMathewsAMBrief standard self-rating for phobic patients. Behaviour Research and Therapy1979; 17:263–267.
15.
HodgsonRJRachmanS.Obsessional–compulsive complaints. Behaviour Research and Therapy1977; 15:389–395.
16.
DharwadkerN.Effectiveness of an assertive outreach community treatment program. Australian and New Zealand Journal of Psychiatry1994; 28:244–249.
17.
HambridgeJARosenA.Assertive community treatment for the seriously mentally ill in suburban Sydney: a programme description and evaluation. Australian and New Zealand Journal of Psychiatry1994; 28:438–455.
18.
SoniSDMallikAReedPGaskellK.Differences between chronic schizophrenic patients in the hospital and in the community. Hospital and Community Psychiatry1992; 43:1233–1238.
19.
MyersJKWeissmanMMTischlerGlSix-month prevalence of psychiatric disorders in three communities: 1980–1982. Archives of General Psychiatry1984; 41:959–967.
20.
HafnerRJCragoAChristensenDLiaBScarboroughA.Training case managers in cognitive-behaviour therapy. Australian and New Zealand Journal of Mental Health Nursing1996; 5:163–170.
21.
GoffDGBrotmanAWWaitesMMcCormickS.Trial of fluoxetine added to neuroleptics for treatment resistant schizophrenic patients. American Journal of Psychiatry1990; 147:492–494.
22.
GoldmanMBJanececkHMAdjunctive fluoxetine improves global function in chronic schizophrenia. Journal of Neuropsychiatry1990; 2:429–431.
23.
ZoharJKaplanZBenjaminJ.Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients. Journal of Clinical Psychiatry1993; 54:385–388.
24.
BermanISapersBChangHHTreatment of obsessive–compulsive symptoms in schizophrenic patients with clomipramine. Journal of Clinical Psychopharmacology1995; 15:206–210.